Evermay Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$248K Hold
1,265
0.03% 174
2025
Q4
$220K Sell
1,265
-213
-14% -$38.8K 0.02% 185
2025
Q3
$282K Sell
1,478
-21
-1% -$3.73K 0.03% 170
2025
Q2
$269K Hold
1,499
0.03% 173
2025
Q1
$254K Hold
1,499
0.03% 171
2024
Q4
$226K Sell
1,499
-202
-12% -$31.4K 0.03% 181
2024
Q3
$264K Sell
1,701
-30
-2% -$4.48K 0.04% 170
2024
Q2
$237K Sell
1,731
-8
-0.5% -$1.1K 0.04% 181
2024
Q1
$231K Hold
1,739
0.04% 187
2023
Q4
$240K Sell
1,739
-20
-1% -$2.63K 0.04% 169
2023
Q3
$214K Buy
1,759
+2
+0.1% +$266 0.04% 162
2023
Q2
$247K Sell
1,757
-1
-0.1% -$138 0.05% 154
2023
Q1
$249K Sell
1,758
-249
-12% -$35.6K 0.05% 151
2022
Q4
$314K Buy
2,007
+1
+0% +$144 0.06% 133
2022
Q3
$246K Sell
2,006
-199
-9% -$26.2K 0.05% 149
2022
Q2
$293K Sell
2,205
-99
-4% -$13.5K 0.06% 135
2022
Q1
$315K Buy
2,304
+1
+0% +$139 0.05% 151
2021
Q4
$398K Sell
2,303
-189
-8% -$28.8K 0.07% 115
2021
Q3
$362K Buy
2,492
+1
+0% +$146 0.07% 113
2021
Q2
$329K Sell
2,491
-148
-6% -$19.4K 0.06% 131
2021
Q1
$339K Sell
2,639
-31
-1% -$3.82K 0.07% 128
2020
Q4
$318K Sell
2,670
-157
-6% -$19.1K 0.07% 129
2020
Q3
$324K Buy
2,827
+1
+0% +$118 0.08% 112
2020
Q2
$322K Buy
+2,826
New +$300K 0.08% 109
2020
Q1
Sell
-1,986
Closed -$212K 141
2019
Q4
$212K Buy
+1,986
New +$207K 0.05% 153

Other funds holding DGX

Evermay Wealth Management's DGX Position: Q1 2026 in Review

Evermay Wealth Management held its Quest Diagnostics (DGX) position steady in Q1 2026 at 1,265 shares worth $248K. The position accounts for 0.03% of the portfolio, ranked #174.

Evermay Wealth Management first reported a position in DGX in Q4 2019 and has held it in 25 quarters since. The position peaked at $398K in Q4 2021. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Evermay Wealth Management held 1,265 shares of Quest Diagnostics worth $248K as of Q1 2026.
  • Evermay Wealth Management left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up 0.03% of Evermay Wealth Management's portfolio in Q1 2026, its #174 holding.
  • Evermay Wealth Management first reported a position in Quest Diagnostics in Q4 2019 and has held it in 25 quarters since.
  • Evermay Wealth Management's Quest Diagnostics position peaked at $398K in Q4 2021.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Evermay Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.